Skip to content
Search

Latest Stories

MG Motor India to boost ventilator production with MAX Ventilator

MG MOTOR INDIA has joined hands with Gujarat-based MAX Ventilator to increase the production of ventilators. Max Ventilator is among the top 25 ventilator brands in the world and caters primarily to the private hospitals.

This collaboration is focussed on assisting the overall production of ventilators by addressing specific areas of the supply chain, IT system and manufacturing processes.


Part of AB Industries, MAX has been manufacturing ventilators for the past 25 years.

With this partnership, the production capacity would be increased five times to 300 ventilators per month in Phase I which should be completed within next eight weeks, said MG Motor India.

In the second phase, the production capacity can be enhanced up to 1,000 ventilators per month, depending upon the demand, especially from the government hospitals to help meet the shortage of the life-saving medical devices in the country, a company statement said.

“At MG, we are committed to supporting our country’s fight against COVID-19 crisis. We understand that ventilators are the most critical requirement at this time, and we would do our best to enhance ventilator production," said Rajeev Chaba, president & managing director, MG Motor India.

"The collaboration comes as a result of aligned core values of both organisations and is designed to work towards the common goal of serving the communities around where our operations are based."

Ashok Patel, MD of A.B. Industries – MAX Ventilator, said: “As a manufacturing company of respiratory ventilators, this collaboration with MG Motor will help us to scale up the production with our teams working together hand in hand. Collaborations like these will guarantee that we meet the requirements to treat the rising COVID-19 cases in India.”

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less